3D Printed Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others), By Application (Orthopedic, Neurology, Dental, Others), By End User (Hospitals & Clincs, Academic & Research Institutions, Others), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

The report will be delivered in PDF format but without printing rights. It is recommended for individual clients for their personal use only.
Single User Licence $4500
The report will be delivered in printable PDF format along with the report’s data excel sheet for internal analysis. It is strongly recommended for a corporate team or an organization where users would like to access the report from multiple locations.!
Multi-User Licence $5500
The report will be delivered in printable PDF format along with the report’s data excel sheet. This license offers free 80 Analyst hours where the client can use TechSci’s research team. It is strongly recommended for an organization which wants to execute short ‘bespoke’ research project related to the scope of the purchased report.!
Custom Research Licence $8000
Main Content start here
Main Layout
Report Description

Report Description

The global 3d printed drugs market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to increasing awareness amongst people and patients regarding the benefits associated with the usage of 3D printed drugs. Besides increasing number of patients suffering from dysphagia is expected to support the market growth in the coming years. Dysphagia is characterized by difficulty in swallowing. In this disease, it takes more time and effort to move food or liquid from mouth to stomach. 3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Besides, increasing investments by government organizations for inventing new drugs related to different diseases couples with growing awareness regarding usage of 3D printed drugs among people and healthcare providers will further boost the market growth in the forecast period. Furthermore, growing popularity of personalized medicine is further expected to create lucrative opportunities for the market growth.

Increasing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, renal problems, among others across the globe is expected to create lucrative opportunities for the growth of global 3D printed drugs market. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This in turn is expected to increase the demand for 3D printed drugs for the treatment of different types of cancers. Additionally, growing geriatric population across the globe which is susceptible to various diseases requires medications that are not only effective but also affordable, thereby fuelling the growth of global 3D printed drugs market.

 

Benefits Associated With 3D Printed Drugs

There are numerous benefits associated with the use of 3D Printed Drugs such as using this technique medicines can be produced in small batches with carefully tailored shapes, dosages, and sizes, among others. In addition, the use of 3D printing technology can significantly reduce manufacturing costs. This in turn is expected to increase investments in this space, thereby supporting the market growth during the forecast period. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

 

Download Free Sample Report

Market Segmentation

The Global 3D Printed Drugs market can be segmented by technology, by application, by end user, and by region. Based on technology, the market can be categorized into inkjet printing, fused deposition modeling, stereolithography, zipdose technology, and others. Based on application, the market can be fragmented into orthopedic, neurology, dental, and others. Based on end user, the market can be grouped into hospitals & clincs, academic & research institutions, and others. Regionally, North America dominated the market among Europe, Asia Pacific, Middle East & Africa, and South America. Among the different countries, United States dominated the Global 3D Printed Drugs Market on account of growing adoption, use and availability of personalized medicines in the United States. The number of personalized medicines available in the United States in 2020 were around 286.

 

Market Players

Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation are some of the leading players operating in the Global 3D Printed Drugs Market.


Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         By Technology

·         By Application

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Turkey; Egypt

Key companies profiled

Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, Global 3D Printed Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

3D Printed Drugs Market, By Technology:

  • Inkjet Printing
  • Fused Deposition Modeling
  • Stereolithography
  • Zip Dose Technology
  • Others

3D Printed Drugs Market, By Application:

  • Orthopedic
  • Neurology
  • Dental
  • Others

3D Printed Drugs Market, By End User:

  • Hospital & Clinics
  • Academic & Research Institutions
  • Others

3D Printed Drugs Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt
     

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global 3D Printed Drugs Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global 3D Printed Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]
Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global 3D Printed Drugs Market

5.    Voice of Customer

6.    Global 3D Printed Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others)

6.2.2.     By Application (Orthopedic, Neurology, Dental, Others)

6.2.3.     By End User (Hospitals & Clincs, Academic & Research Institutions, Others)

6.2.4.     By Company (2021)

6.2.5.     By Region

6.3.  Market Map

7.    North America 3D Printed Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Application

7.2.3.     By End User

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States 3D Printed Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Technology

7.3.1.2.2.             By Application

7.3.1.2.3.             By End User

7.3.2.     Canada 3D Printed Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Technology

7.3.2.2.2.             By Application

7.3.2.2.3.             By End User

7.3.3.     Mexico 3D Printed Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Technology

7.3.3.2.2.             By Application

7.3.3.2.3.             By End User

8.    Europe 3D Printed Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Application

8.2.3.     By End User

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France 3D Printed Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Technology

8.3.1.2.2.             By Application

8.3.1.2.3.             By End User

8.3.2.     Germany 3D Printed Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Technology

8.3.2.2.2.             By Application

8.3.2.2.3.             By End User

8.3.3.     United Kingdom 3D Printed Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Technology

8.3.3.2.2.             By Application

8.3.3.2.3.             By End User

8.3.4.     Italy 3D Printed Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Technology

8.3.4.2.2.             By Application

8.3.4.2.3.             By End User

8.3.5.     Spain 3D Printed Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Technology

8.3.5.2.2.             By Application

8.3.5.2.3.             By End User

9.    Asia-Pacific 3D Printed Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Application

9.2.3.     By End User

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China 3D Printed Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Technology

9.3.1.2.2.             By Application

9.3.1.2.3.             By End User

9.3.2.     India 3D Printed Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Technology

9.3.2.2.2.             By Application

9.3.2.2.3.             By End User

9.3.3.     Japan 3D Printed Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Technology

9.3.3.2.2.             By Application

9.3.3.2.3.             By End User

9.3.4.     South Korea 3D Printed Drugs Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Technology

9.3.4.2.2.             By Application

9.3.4.2.3.             By End User

9.3.5.     Australia 3D Printed Drugs Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Technology

9.3.5.2.2.             By Application

9.3.5.2.3.             By End User

10.  South America 3D Printed Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Technology

10.2.2.  By Application

10.2.3.  By End User

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil 3D Printed Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Technology

10.3.1.2.2.           By Application

10.3.1.2.3.           By End User

10.3.2.  Argentina 3D Printed Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Technology

10.3.2.2.2.           By Application

10.3.2.2.3.           By End User

10.3.3.  Colombia 3D Printed Drugs Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Technology

10.3.3.2.2.           By Application

10.3.3.2.3.           By End User

11.  Middle East and Africa 3D Printed Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Technology

11.2.2.  By Application

11.2.3.  By End User

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa 3D Printed Drugs Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Technology

11.3.1.2.2.           By Application

11.3.1.2.3.           By End User

11.3.2.  Saudi Arabia 3D Printed Drugs Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Technology

11.3.2.2.2.           By Application

11.3.2.2.3.           By End User

11.3.3.  UAE 3D Printed Drugs Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Technology

11.3.3.2.2.           By Application

11.3.3.2.3.           By End User

11.3.4.  Turkey 3D Printed Drugs Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Technology

11.3.4.2.2.           By Application

11.3.4.2.3.           By End User

11.3.5.  Egypt 3D Printed Drugs Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Technology

11.3.5.2.2.           By Application

11.3.5.2.3.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Aprecia Pharmaceuticals, LLC.

14.2.              FabRx Ltd.

14.3.              Merck & Co. Inc.

14.4.              Triastek, Inc.

14.5.              GlaxoSmithKline plc.

14.6.              Formac Pharmaceuticals N.V.

14.7.              AstraZeneca plc

14.8.              Extend Biosciences, Inc.

14.9.              Affinity Therapeutics, LLC

14.10.            Osmotica Pharmaceuticals Corporation

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

Frequently asked questions

Rising prevalence of chronic diseases combined with the rising population of patients with dysphagia around the globe are some of the major drivers for the global 3D printed drugs market.

Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation are some of the leading players operating in the Global 3D Printed Drugs Market.

Inkjet technology segment is the expected to dominate in the global 3D printed drugs market during the forecast period.

North America region is estimated to hold the largest share in the Global 3D Printed Drugs Market.

Related Reports

Related Reports